Drug intelligence / Profile preview

ginsenoside Rg5

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Ginsenoside Rg5 is a rare tetracyclic triterpenoid saponin primarily derived from red ginseng (*Panax ginseng*) through the steaming and drying process of white ginseng. It has demonstrated significant pharmacological potential, particularly as an anti-cancer agent. Mechanistically, Rg5 has been shown to inhibit colorectal cancer progression by acting as an autophagy inhibitor; it specifically targets and inhibits the ATP6V1A subunit of the vacuolar-type H+-ATPase (V-ATPase), which blocks lysosomal degradation and autophagic flux, ultimately triggering apoptosis. Beyond oncology, Rg5 is researched for its anti-inflammatory, neuroprotective, and anti-diabetic effects, often modulating pathways such as NF-κB and PI3K/Akt.

Other names
Rg5 ginsenosideRg-5 ginsenosideRg 5 ginsenoside
02

Targets

ATP6V1B2 (V-type proton ATPase subunit B2)

Beyond the preview

Go deeper on ginsenoside Rg5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginsenoside Rg5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call